A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment

Measurement of muscle strength and activity of upper limbs of non-ambulant patients with neuromuscular diseases is a major challenge. ActiMyo® is an innovative device that uses magneto-inertial sensors to record angular velocities and linear accelerations that can be used over long periods of time in the home environment. The device was designed to insure long-term stability and good signal to noise ratio, even for very weak movements. In order to determine relevant and pertinent clinical variables with potential for use as outcome measures in clinical trials or to guide therapy decisions, we performed a pilot study in non-ambulant neuromuscular patients. We report here data from seven Duchenne Muscular Dystrophy (DMD) patients (mean age 18.5 ± 5.5 years) collected in a clinical setting. Patients were assessed while wearing the device during performance of validated tasks (MoviPlate, Box and Block test and Minnesota test) and tasks mimicking daily living. The ActiMyo® sensors were placed on the wrists during all the tests. Software designed for use with the device computed several variables to qualify and quantify muscular activity in the non-ambulant subjects. Four variables representative of upper limb activity were studied: the rotation rate, the ratio of the vertical component in the overall acceleration, the hand elevation rate, and an estimate of the power of the upper limb. The correlations between clinical data and physical activity and the ActiMyo® movement parameters were analyzed. The mean of the rotation rate and mean of the elevation rate appeared promising since these variables had the best reliability scores and correlations with task scores. Parameters could be computed even in a patient with a Brooke functional score of 6. The variables chosen are good candidates as potential outcome measures in non-ambulant patients with Duchenne Muscular Dystrophy and use of the ActiMyo® is currently being explored in home environment. Trial Registration: ClinicalTrials.gov NCT01611597

[1]  A. Emery.  Population frequencies of inherited neuromuscular diseases—A world survey , 1991, Neuromuscular Disorders.

[2]  Elske Ammenwerth,et al.  Measurement and quantification of generalized tonic–clonic seizures in epilepsy patients by means of accelerometry—An explorative study , 2011, Epilepsy Research.

[3]  C. McDonald.  Physical activity, health impairments, and disability in neuromuscular disease. , 2002, American journal of physical medicine & rehabilitation.

[4]  Fabiana Luisa Mattar,et al.  Hand weakness in Duchenne muscular dystrophy and its relation to physical disability , 2008, Neuromuscular Disorders.

[5]  M. Grootenhuis,et al.  Living with muscular dystrophy: health related quality of life consequences for children and adults , 2007, Health and quality of life outcomes.

[6]  R. Carson,et al.  Upper vs lower extremity functional loss in neuromuscular disease. , 1987, Archives of physical medicine and rehabilitation.

[7]  V. Ricotti,et al.  Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study , 2014, The Lancet Neurology.

[8]  Nicolas Petit,et al.  Iterative calibration method for inertial and magnetic sensors , 2009, Proceedings of the 48h IEEE Conference on Decision and Control (CDC) held jointly with 2009 28th Chinese Control Conference.

[9]  John L. Crassidis,et al.  Survey of nonlinear attitude estimation methods , 2007 .

[10]  Pierre J. M. Cluitmans,et al.  Detection of Subtle Nocturnal Motor Activity From 3-D Accelerometry Recordings in Epilepsy Patients , 2007, IEEE Transactions on Biomedical Engineering.

[11]  F. Horak,et al.  Assessing mobility at home in people with early Parkinson's disease using an instrumented Timed Up and Go test. , 2011, Parkinsonism & related disorders.

[12]  Ilaria Carpinella,et al.  Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test , 2014, Journal of NeuroEngineering and Rehabilitation.

[13]  P. Zimetbaum,et al.  Ambulatory arrhythmia monitoring: choosing the right device. , 2010, Circulation.

[14]  Brian W. Timmons,et al.  Accelerometry: A Feasible Method to Quantify Physical Activity in Ambulatory and Nonambulatory Adolescents with Cerebral Palsy , 2012, International journal of pediatrics.

[15]  Ruzena Bajcsy,et al.  Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases , 2013, PLoS currents.

[16]  L. Servais,et al.  Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy , 2016, Neurology.

[17]  Vincent Bonnet,et al.  Estimate of lower trunk angles in pathological gaits using gyroscope data. , 2013, Gait & posture.

[18]  Philippe Kahane,et al.  Classification of epileptic motor manifestations using inertial and magnetic sensors , 2011, Comput. Biol. Medicine.

[19]  Roslyn N. Boyd,et al.  Validity of accelerometry in ambulatory children and adolescents with cerebral palsy , 2011, European Journal of Applied Physiology.

[20]  J. Fermanian,et al.  [A motor function measurement scale for neuromuscular diseases - description and validation study]. , 2006, Revue neurologique.

[21]  R. Abresch,et al.  Utility of a step activity monitor for the measurement of daily ambulatory activity in children. , 2005, Archives of physical medicine and rehabilitation.

[22]  Kun-Chan Lan,et al.  On Calibrating the Sensor Errors of a PDR-Based Indoor Localization System , 2013, Sensors.

[23]  L. Hiller,et al.  Upper extremity functional assessment scales in children with Duchenne muscular dystrophy: a comparison. , 1992, Archives of physical medicine and rehabilitation.

[24]  Carole Bérard,et al.  La mesure de fonction motrice, outil d’évaluation clinique des maladies neuromusculaires. Étude de validation , 2006 .

[25]  D. Escolar,et al.  Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children , 2001, Muscle & nerve.

[26]  J. Mendell,et al.  Eteplirsen for the treatment of Duchenne muscular dystrophy , 2013, Annals of neurology.

[27]  Sean Pearson,et al.  Continuous Monitoring of Turning in Patients with Movement Disability , 2013, Sensors.

[28]  C. Vandelanotte,et al.  Socio-demographic factors and neighbourhood social cohesion influence adults’ willingness to grant children greater independent mobility: A cross-sectional study , 2015, BMC Public Health.

[29]  R. Motl,et al.  Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data , 2010, Multiple sclerosis.

[30]  G. van Ommen,et al.  Systemic administration of PRO051 in Duchenne's muscular dystrophy. , 2011, The New England journal of medicine.

[31]  Domenico Formica,et al.  A New Calibration Methodology for Thorax and Upper Limbs Motion Capture in Children Using Magneto and Inertial Sensors , 2014, Sensors.

[32]  Kamiar Aminian,et al.  Gait Assessment in Children With Duchenne Muscular Dystrophy During Long-Distance Walking , 2012, Journal of child neurology.

[33]  R. Finkel,et al.  The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability , 2010, Neuromuscular Disorders.

[34]  Nathalie Jette,et al.  A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy , 2014, Neuromuscular Disorders.

[35]  Ruzena Bajcsy,et al.  Development and Application of Stereo Camera-Based Upper Extremity Workspace Evaluation in Patients with Neuromuscular Diseases , 2012, PloS one.

[36]  E. Mazzone,et al.  A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy , 2012, Developmental medicine and child neurology.

[37]  M. Brooke,et al.  Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.

[38]  Susanne Fuchs-Winkelmann,et al.  Objective assessment, repeatability, and agreement of shoulder ROM with a 3D gyroscope , 2013, BMC Musculoskeletal Disorders.

[39]  Robert E. Mahony,et al.  Attitude estimation on SO[3] based on direct inertial measurements , 2006, Proceedings 2006 IEEE International Conference on Robotics and Automation, 2006. ICRA 2006..

[40]  J. Mendell,et al.  Reliability and validity of active‐seated: An outcome in dystrophinopathy , 2015, Muscle & nerve.

[41]  J. Bourke,et al.  Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study , 2011, The Lancet.

[42]  F. Horak,et al.  Trunk accelerometry reveals postural instability in untreated Parkinson's disease. , 2011, Parkinsonism & related disorders.

[43]  J. Vissing,et al.  Decreased Variability of the 6-Minute Walk Test by Heart Rate Correction in Patients with Neuromuscular Disease , 2014, PloS one.

[44]  V. Mathiowetz,et al.  Adult norms for the Box and Block Test of manual dexterity. , 1985, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[45]  Elizabeth Vroom,et al.  Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy , 2013, Developmental medicine and child neurology.

[46]  G. V. Ommen,et al.  Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy , 2002, Neuromuscular Disorders.

[47]  L. Andersen,et al.  Health‐related aspects of objectively measured daily physical activity in children , 2008, Clinical physiology and functional imaging.

[48]  J. Thonnard,et al.  ABILHAND: a Rasch-built measure of manual ability. , 1998, Archives of physical medicine and rehabilitation.

[49]  J. Miller,et al.  Outcome reliability in non‐Ambulatory Boys/Men with duchenne muscular dystrophy , 2015, Muscle & nerve.

[50]  Henk J Stam,et al.  Excellent test-retest and inter-rater reliability for Tardieu Scale measurements with inertial sensors in elbow flexors of stroke patients. , 2011, Gait & posture.

[51]  Kamiar Aminian,et al.  Continuous monitoring and quantification of multiple parameters of daily physical activity in ambulatory Duchenne muscular dystrophy patients. , 2011, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[52]  M. Main,et al.  The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[53]  Fendy Santoso,et al.  Indoor location-aware medical systems for smart homecare and telehealth monitoring: state-of-the-art , 2015, Physiological measurement.

[54]  H. Stam,et al.  Upper limb function in adults with Duchenne muscular dystrophy. , 2011, Journal of rehabilitation medicine.

[55]  T. Voit,et al.  Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients , 2013, Neuromuscular Disorders.

[56]  G. Wahba.  A Least Squares Estimate of Satellite Attitude , 1965 .

[57]  L. Servais,et al.  Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial , 2015, PloS one.

[58]  Fabrizio Taffoni,et al.  A technological approach to studying motor planning ability in children at high risk for ASD , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[59]  M G Wardle,et al.  Use of the Minnesota Rate of Manipulation Test for Disability Evaluation , 1982, Perceptual and motor skills.

[60]  Jay J. Han,et al.  The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy , 2010, Muscle & nerve.

[61]  J. Téllez-Zenteno,et al.  Ambulatory EEG: a cost-effective alternative to inpatient video-EEG in adult patients , 2012, Epileptic disorders : international epilepsy journal with videotape.

[62]  Don C Des Jarlais,et al.  Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. , 2004, American journal of public health.

[63]  G.H. Elkaim,et al.  Extension of a two-step calibration methodology to include nonorthogonal sensor axes , 2008, IEEE Transactions on Aerospace and Electronic Systems.

[64]  M. Rose,et al.  Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL) , 2007, Neurology.

[65]  A. Emery,et al.  The muscular dystrophies , 2002, The Lancet.

[66]  Nicolas Petit,et al.  Using magnetic disturbances to improve IMU-based position estimation , 2007, 2007 European Control Conference (ECC).

[67]  Francesco Muntoni,et al.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.

[68]  Sabine Van Huffel,et al.  Long-term home monitoring of hypermotor seizures by patient-worn accelerometers , 2013, Epilepsy & Behavior.

[69]  Ronald M. Aarts,et al.  Time-Frequency Analysis of Accelerometry Data for Detection of Myoclonic Seizures , 2010, IEEE Transactions on Information Technology in Biomedicine.

[70]  L. Servais,et al.  Upper Limb Evaluation and One-Year Follow Up of Non-Ambulant Patients with Spinal Muscular Atrophy: An Observational Multicenter Trial , 2015, PloS one.